TYVPANASL TFA

This product is the HER2/neu-derived peptide TYVPANASL (TFA salt), a nine-residue CD8+ T-cell epitope that binds MHC I. It is a key component in J-LEAPS vaccine constructs for cancer immunotherapy research, enabling studies of antigen-specific T-cell responses in both in vitro and in vivo experimental models.